🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

What a pleasure to host University of Padova PANC-PALS local PI, Giovanni Marchegiani, at our HQ this week! 💜 Great discussions followed by a drink by the East River 😎 #PANCPALS

Hora est! 🎓 PhD cerimony in 🇳🇱 is just something different… with two ⭐️⭐️ like Ammar Asrar Javed, MD PhD 🇺🇸 and Joe Habib then it’s glorious! Thank you for having me in this fantastic IPMN journey between 🇺🇸 and 🇪🇺 Looking forward to the next steps (and to be as tall as Marc Besselink 😂)

🚨 FOLFIRINOX vs. GEM Nab Paclitaxel for LAPC 💉 171 pts median PFS 9 months better in FOLFIRINOX group 🎯 FOLFIRINOX improves PFS significantly compared with gemcitabine and is well tolerated in LAPC 🔥ascopubs.org/doi/10.1200/JC…

Turning ambitious ideas 💡 into reality with Livia Archibugi my_UEG and EPC-Europ Pancr Club !!! 🟢 The quality indicators in pancreas cancer project is now up and running.. to elevate the level of care in Europe and beyond! Thank you to all the amazing experts for participating! 🚀

🔵 Surgery for chronic pancreatitis across Europe 🇪🇺 22 centres in 13 countries 🪡 200 surgeries 💊 50% did opiod before 🤒 14% major morbidity / 1.4% mortality 👍 Pain relieved 72% 😎 Reported good pain relief and improvements in quality-of-life academic.oup.com/bjs/article/11…

Anatomically resectable 🆚 biologically borderline PDAC 🩻 886 pts with identical imaging appearance 🪡 With upfront surgery 🧪 Biologically BR had worse DSS (54 vs. 27 months) ✌️different entities ✌️different approaches academic.oup.com/bjsopen/articl…

✂️ Arterial resection and divestment 🔟 year comparative study 🇯🇵 Analysis of 200 PDAC + artery 👗 Divestment (120 cases) most used in first 5 years 🎖️Last 5 years ⬆️ Neoadjuvant chemo + resection ⬇️ complications 👍 academic.oup.com/bjsopen/articl…

Postop ⬆️ amylasemia and acute pancreatitis 🧪 systematic review and meta analysis 🐳 POH predicts POPF ⚡️ PPAP causes POPF, DGE, PPH and mortality 👉 Check amylase early and get ready to mitigate 🧯postop complications! sciencedirect.com/science/articl…

🚨 From ASCO 2025 👉 Preop chemo with PAXG 🆚 mFOLFIRINOX for extending event-free survival (EFS) in resectable or BR PDAC (phase 3 CASSANDRA trial) 🆙 PAXG 3-year EFS 31% vs. 13% P = .003 🫸 Immature analysis for survival but.. future practice changing?! 🧐

IPMN 🍇 without HRS and long term risk of cancer development 🇯🇵 2.5k pts > 5 years surveillance 🫧 IPMN size and growth predict cancer within 5 years 🤏 MPD diameter at 5 years predicts cancer after 5 years gut.bmj.com/content/74/6/9…

☘️ We are ready to welcome 🤗 you in Dublin 🇮🇪 for a glorious E-AHPBA 2025!!! Stay tuned for 4 days of science, surgery and friendship!

🔥 Hot takes from E-AHPBA 2025 🇮🇪 🇳🇴 Knut Jørgen Labori on resectable PDAC - reflections after the NORPACT trial 🚨 Which are the non surgical elements of neoadjuvant chemo?! How do they affect our practice ?! 🧐 Very thoughtful one!

🔥 Hot takes from E-AHPBA 2025 🇮🇪 🇳🇱 Bas Groot Koerkamp on the challenges of BR and LA PDAC 💉 How long should chemo be delivered for?! When to consider a chemoswitch?! 🟰 No Benefit (yet) of Folfirinox over GEM-Nab in survival 🧪 If CA19.9 not meaningful consider FdgPET

🔔 The new European Multi-societal Guidelines on pancreas cancer have reached now an advanced status and will be finalized soon 3️⃣0️⃣ Societes under the auspices of E-AHPBA and #ESSO 3️⃣9️⃣ evidence based recommendations 👏 To the amazing young doctors and Phds involved!!!

My invited talk at E-AHPBA 2025 🇮🇪 was about IPMN 🍇 and related carcinoma A very slippery 🧽 topic!!! Indeed 2️⃣ different entities in 1️⃣… IPMN derived cancer follow distinct 🧬 pathways 🆚 conventional PDAC but are way less explored (NOT a single RCT) 👉 knowledge gap!

Fantastic report on the hot topic 🔥 by the unrivaled Giovanni Marchegiani! Valuable insights from the top expert on IPMN 💯🔝💡! Truly impressive, as expected 💪🏼!!! E-AHPBA #EAHPBA2025 #EAHPBA25 #EAHPBA #PancreaticCancer #IPMN #PancreaticSurgery

✨ Highlights from JSHBPS2025 第37回日本肝胆膵外科学会学術集会 🇯🇵 🎙️ Inspiring YosukeInoueHPB on Central Vascular ligation in PD 🌿 SMA is approached from both 👉 right and 👈 left side 🔪 Open approach right anterior 🤖 Robot approach left posterior 🤯 Absolute masterclass of surgical oncology 👏

You just can’t stop learning from Japanese surgeons 🇯🇵 !!! 🫀Meticulous anatomy study + 🪡 outstanding surgical technique… what else?! 🙏 Thank you JSHBPS2025 第37回日本肝胆膵外科学会学術集会 for such an amazing human and professional experience

🚨 New Impact Factors for HPB surgery science are out! 🚨 🥇JAMA Surgery 14.9 🥈BJS 8.8 🥉Annals of Surgery 6.4 And following… ⭐️ BJS Open 4.5 Ann Surg Oncol 3.5 JACS 3.4 EJSO 2.9 Surgery 2.7 Surg Endosc 2.7 WJS 2.5 HPB 2.4 Langenbeck’s 1.8 Thanks Ville Sallinen 🏆

“I see pancreas everywhere” - Tokyo 🇯🇵 edition